Casebia Therapeutics
Get Full AccessDescription
- Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing technology applications to patients.
-
Headquarters:610 Main Street , Cambridge, Massachusetts, United States
More -
Phone Number: +1 857-270-5100
-
Website: https://www.casebia.com
-
Employees:47
-
Revenue:$50 - 100M
-
Legal Name:Casebia Therapeutics
-
Casebia Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 999990 |
Show More
Frequently Asked Questions regarding Casebia Therapeutics
-
Where are Casebia Therapeutics's Headquarters?
Casebia Therapeutics's Headquarters are in 610 Main Street ,Cambridge,Massachusetts,United States
-
What is Casebia Therapeutics's phone number?
Casebia Therapeutics's phone number is +1 857-270-5100
-
What is Casebia Therapeutics's official website?
Casebia Therapeutics's official website is https://www.casebia.com
-
What is Casebia Therapeutics's Revenue?
Casebia Therapeutics's revenue is $50 - 100M
-
What is Casebia Therapeutics's NAICS code?
Casebia Therapeutics's NAICS code is 999990
-
How many employees are working in Casebia Therapeutics
Casebia Therapeutics has 47 employees
-
What is Casebia Therapeutics's Industry?
Casebia Therapeutics is in the industry of Biotechnology
-
Who is Casebia Therapeutics's Senior Vice President Operations?
Casebia Therapeutics's Senior Vice President Operations is Ellen Ridge

